Anticonvulsants for neuropathic pain syndromes: Mechanisms of action and place in therapy

Drugs

Volumn 60, Issue 5, 2000, Pages 1029-1052

  Tremont Lukats, Ivo W ^a   Megeff, Carla ^b   Backonja, Misha Miroslav ^a,c  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^b ST LOUIS COLLEGE OF PHARMACY   (United States)

^c University of Wisconsin Health   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMITRIPTYLINE; ANTICONVULSIVE AGENT; BENZODIAZEPINE DERIVATIVE; BUPRENORPHINE; CARBAMAZEPINE; CLOMIPRAMINE; CLONAZEPAM; DIHYDROCODEINE; FELBAMATE; FLUPHENAZINE; GABAPENTIN; LAMOTRIGINE; LORAZEPAM; NITRAZEPAM; NORTRIPTYLINE; PHENOBARBITAL; PHENYTOIN; PIMOZIDE; PREGABALIN; TIAGABINE; TIZANIDINE; TOCAINIDE; TOPIRAMATE; VALPROIC ACID; VIGABATRIN; ZONISAMIDE;

CANCER PAIN; CARPAL TUNNEL SYNDROME; CHRONIC PAIN; CLINICAL TRIAL; DEPRESSION; DIABETIC NEUROPATHY; DOSE RESPONSE; DROWSINESS; DRUG MECHANISM; EPILEPSY; HUMAN; NERVE CELL PLASTICITY; NEUROPATHY; NONHUMAN; PATHOPHYSIOLOGY; POSTHERPETIC NEURALGIA; RETINA DISEASE; REVIEW; TRIGEMINUS NEURALGIA; VERTIGO;

EID: 0033663222     PISSN: 00126667     EISSN: None     Source Type: Journal    
DOI: 10.2165/00003495-200060050-00005     Document Type: Review

References (161)

1. A peripheral mononeuropathy in the rat that produces disorders of pain sensation like those seen in man
2. Pain and central nervous system disease: A summary and overview
3. Properties of afferent nerve impulses originating from a neuroma
4. A novel behavioral model of neuropathic pain disorders produced in rats by partial sciatic nerve injury
5. Sympathetic sprouting in the dorsal root ganglia of the injured peripheral nerve in a rat neuropathic pain model
6. Characterization of a neuropathic pain model: Sciatic cryoneurolysis in the rat
7. Possible chemical contribution from chronic gut sutures produces disorders of pain sensation like those seen in man
8. Pain, hyperalgesia and activity in nociceptive C units in humans after intradermal injection of capsaicin
9. An animal model of neuropathic pain: A review
10. Spinal cord pharmacology of pain
11. Inflammatory pain sensitivity mediated by phenotypic switch in myelinated primary senory neurons
12. The contribution of excitatory amino-acids to central sensitization and persistent nociception after formalin-induced tissue injury
13. The effects of mexiletine, desipramine and fluoxetine in rat models involving central sensitization
14. Nociceptor modulated central sensitization causes mechanical hyperalgesia in acute chemogenic and chronic neurogenic pain
15. The induction and maintenance of central sensitization is dependent on N-methyl-D-aspartic acid receptor activation; implications for the treatment of post-injury pain hypersensitivity states
16. Mechanical hyperalgesias in neuropathic pain patients: Dynamic and static subtypes
17. The relationship between sensor thresholds and mechanical hyperalgesia in nerve injury
18. Dynamic and static components of mechanical hyperalgesia in human hairy skin
19. Chronic hyperalgesia and skin warming caused by sensitized C nociceptors
20. Peripheral neural mechanisms of cutaneous hyperalgesia following mild injury by heat
21. Cutaneous hyperalgesia: Contributions of the peripheral and central nervous system to the increase in pain sensitivity after injury
22. The thermal grill illusion: Unmasking the burn of cold pain
23. Excitatory amino acids in health and disease
24. Drugs acting on the central nervous system
25. A mechanism of carbamazepine analgesia as shown by bradykinin-induced trigeminal pain
26. Carbamazepine inhibits spontaneous activity in experimental neuromas
27. Effects of systemic carbamazepine and gabapentin on spinal neuronal responses in spinal nerve ligated rats
28. Combined neurogenic and nociceptive pain in a patient with Pancoast tumor managed by epidural hydromorphone and oral carbamazepine
29. Analgesic concentrations of lidocaine suppress tonic A-delta and C fiber discharges produced by acute injury
30. Trigeminal neuralgia: Its treatment with a new anticonvulsant drug
31. Tic douloureoux treated with new anticonvulsants
32. Clinical trial of carbamazepine (Tegretol) in trigeminal neuralgia
33. Carbamazepine in the treatment of neuralgia
34. Symptomatic treatment of peripheral diabetic neuropathy with carbamazepine: Double-blind crossover study
35. A four year double blind randomized study of tegretol in facial pain
36. Tegretol in the treatment of diabetic neuropathy
37. Tizanidine in the management of trigeminal neuralgia
38. The analgesic effect of tocainide in trigeminal neuralgia
39. Pimozide therapy for trigeminal neuralgia
40. Central post-stroke pain: A controlled trial of amitriptyline and carbamazepine
41. Nortriptyline-fluphenazine vs. carbamazepine in the symptomatic treatment of diabetic neuropathy
42. Phenytoin in the treatment of diabetic symmetrical polyneuropathy
43. Double blind study of the effects of dyphenylhidantoin sodium in diabetic neuropathy
44. Phenytoin as a coanalgesic in cancer pain
45. Intravenous infusion of phenytoin relieves neuropathic pain: A randomized, double-blinded, placebo-controlled, crossover study
46. Amitriptyline, but not lorazepam, relieves postherpetic neuralgia
47. Valproate for treatment of chronic central pain after spinal cord injury: A double-blind cross-over study
48. Lamotrigine (Lamictal) in refractory trigeminal neuralgia: Results from a double-blind placebo controlled crossover trial
49. A placebo-controlled trial of lamotrigine for painful HIV-associated neuropathy
50. 200 mg daily of lamotrigine has no analgesic effect in neuropathic pain: A randomised, double-blind, placebo controlled trial
51. Gabapentin for the symptomatic treatment of painful neuropathy in patients with diabetes mellitus: A randomized controlled trial
52. Gabapentin for the treatment of post-herpetic neuralgia: A randomized controlled trial
53. Randomized double-blind study comparing the efficacy of gabapentin with amithptyline on diabetic peripheral neuropathy pain
54. Analgesic effects of lamotrigine and phenytoin on cold-induced pain: A crossover placebo-controlled study in healthy volunteers
55. Controlled sequential trials of carbamazepine in trigeminal neuralgia
56. Studies on the concomitant use of carbamazepine and clomipramine for the relief of post-herpetic neuralgia
57. The treatment of trigeminal neuralgia
58. Postsympathectomy neuralgia: Amelioration with diphenylhidantoin and carbamazepine
59. Diabetic peripheral neuropathy: Nerve conduction studies before, during, and after carbamazepine therapy
60. Carbamazepine therapy in trigeminal neuralgia: Clinical effects in relation to plasma concentration
61. Long-term treatment of trigeminal neuralgia with carbamazepine
62. Sodium valproate in trigeminal neuralgia
63. Anticonvulsant drugs in the treatment of lancinating pain: A comparison
64. Clonazepam in facial neuralgia and cluster headache: Clinical and electrophysiological study
65. Treatment of tic douloureux with a new anticonvulsant (Clonazepam)
66. Clonazepam in cranial neuralgias
67. Clonazepam in the treatment of neuralgic pain syndrome
68. The effect of gabapentin on neuropathic pain
69. Effects of gabapentin on different components of peripheral and central neuropathic pain syndromes: A pilot study
70. An open-label trial of gabapentin treatment of paroxysmal symptoms in multiple sclerosis patients
71. Lamotrigine control of trigeminal neuralgia
72. Clinical effectiveness of lamotrigine and plasma levels in essential and symptomatic trigeminal neuralgia
73. Lamotrigine in the treatment of painful diabetic neuropathy
74. Lamotrigine adjunctive therapy in painful phenomena in MS: Preliminary observations
75. Potential role of topiramate in relief of neuropathic pain
76. Treatment of post-herpetic neuralgia
77. Clomipramine and amitriptyline in the treatment of severe pain
78. Amitriptyline versus placebo in pos herpetic neuralgia
79. A comparative trial of amitriptyline and simelidine in post herpetic neuralgia
80. Gabapentin (GBP) versus carbamazepine in conservative treatment of carpal tunnel syndrome
81. Cures heureuses de nevralgies faciales essentielles par diphenyl-hidantoinate de soude
82. Anticonvulsant drugs and chronic pain
83. Phenytoin suppresses spontaneous ectopic discharge in rat sciatic nerve neuromas
84. The effect of diphenylhydantoin on self-mutilation in rats produced by unilateral multiple dorsal rhizotomy
85. The effect of novel anti-epileptic drugs in rat experimental models of acute and chronic pain
86. Anticonvulsant drugs for management of pain: A systematic review
87. Treatment of diabetic neuropathy with diphenylhidantoin
88. Gabapentin versus amitriptyline in painful diabetic neuropathy in the elderly
89. Comparative effectiveness of anti-epileptic preparations in treatment of patients with neuralgia of the trigeminal nerve
90. Trigeminal neuralgia treated with G 32.883
91. Eroffnet tegretal neue therapiemoglichkeiten bei bestimmten neurologischen und endokrinen krankheitsbildern? Eine klinische elektroenzephalographische und dunnschichtchromatographische studie
92. A new agent in the treatment of tic douloureoux
93. Evaluation of carbamazepine in the management of tic douloureux and other painful disorders
94. Facial pain treated with carbamazepine (Tegretol)
95. Le traitement de la nevralgie faciale essentielle par le dimethyl-dithio-hydantoine
96. Die behandlung der trigeminusneuralgie mit diphenylhidantoin
97. Phenytoin in the treatment of trigeminal and other neuralgias
98. Felbamate relieved trigeminal neuralgia
99. Gabapentin in idiopathic trigeminal neuralgia
100. Gabapentin (GBP) in painful AIDS-related neuropathy
101. Gabapentin in the treatment of distal symmetric axonopathy in HIV infected patients
102. Carbamazepine for phantom-limb phenomena
103. Lamotrigine for pain with hyperalgesia
104. Clonazepam for the treatment of lancinating phantom limb pain
105. Treatment of paroxysmal disorders in multiple sclerosis with carbamazepine (Tegretol)
106. Painful tonic seizure in multiple sclerosis
107. Gabapentin relieves trigeminal neuralgia in multiple sclerosis patients
108. Lamotrigine can reduce neurogenic pain associated with multiple sclerosis
109. Phenytoin in reflex sympathetic dystrophy
110. Gabapentin in the management of reflex sympathetic dystrophy
111. Gabapentin adjunctive therapy in neuropathic pain states
112. Experience with gabapentin for neuroapthic pain in the head and neck: Report of ten cases
113. Gabapentin for treatment of pain and tremor
114. Gabapentin as an adjuvant to opioid analgesia for neuropathic cancer pain
115. Denervation hyperpathia: A convulsive syndrome of the spinal cord responsive to carbamazepine therapy
116. Post hemiplegic epilepsy in the elderly
117. Phenytoin treatment of thalamic pain
118. A brief trial of phenytoin for thalamic pain
119. Neuropathic pain in the cancer patient
120. GABAergic mechanisms of analgesia: An update
121. The novel analgesic compound OT-7100 attenuates mechanical nociceptive responses in animal models of acute and peripheral neuropathic hyperalgesia
122. Intravenous lorazepam for pain relief of intractable neuralgia
123. The effects of anticonvulsant drugs on NMDA-EPSP, AMPA-EPSP, and GABA-IPSP in the rat hippoccampus
124. Sodium dipropylacetate
125. Antinociceptive action of sodium valproate in the mouse
126. Antinociceptive activity of sodium valproate in mice after chronic treatment
127. Peripheral GABA-A receptor-mediated effects of sodium valproate on dural plasma protein extravasation to subsance P and trigeminal stimulation
128. The actions of valproate and neurosteroids in a model of trigeminal pain
129. GABAergic agents-induced antinociceptive effect in mice
130. The management of post herpetic pain using sodium valproate and amitriptyline
131. A case of tabes dorsalis with tonic pupils and lightning pains relieved by sodium valproate
132. Pharmacological studies on lamotrigine, a novel potential antiepileptic drug. II. Neurochemical studies on the mechanism of action
133. Analgesic reflects of lamotrigine in an experimental model of neuropathic pain in rats
134. Effect of lamotrigine in the acute and chronic hyperalgesia induced by PGE2 and in the chronic hyperalgesia in rats with streptozotocin-induced diabetes
135. Effects of intrathecally administered lamotrigine, a glutamate release inhibitor, on short- and long-term models of hyperalgesia in rats
136. Effect of lamotrigine on the development of neurogenic pain syndrome in rats
137. A summary of mechanistic hypotheses of gabapentin pharmacology
138. Gabapentin and pregabalin, but not morphine and amitriptyline, block both static and dynamic components of mechanical allodynia induced by streptozocin in the rat
139. The anti-allodynic effects of amytriptyline, gabapentin, and lidocaine in a rat model of neuropathic pain
140. Gabapentin suppresses ectopic nerve discharges
141. Gabapentin reverses the allodynia produced by the administration of anti-GD2 ganglioside, and immunotherapeutic drug
142. The effect of gabapentin on brain gamma-aminobutyric acid in patients with epilepsy
143. Gabapentin is effective in treating nocturnal painful spasms in muktiple sclerosis
144. Neurontin (Gabapentin, GBP) improves quality of life (QOL) in patients with painful diabetic peripheral neuropathy
145. Gabapentin in the treatment of painful diabetic neuropathy: A placebo-controlled, double-blind, crossover trial
146. Effect of gabapentin compared to amitriptyline on pain in diabetic peripheral neuropathy
147. Efficacy and safety of topiramate in the treatment of painful diabetic neuropathy: A double-blind, placebo-controlled study
148. A double-blind, placebo-control trial of pregabalin for the treatment of painful diabetic peripheral neuropathy
149. Topiramate: Pharmacokinetics and pharmacodinamics
150. Topiramate relieves refractory intercostal neuralgia
151. Antinociceptive effects of phenobarbital in 'tail-flick' and deafferentation pain
152. Mechanism of action of the anticonvulsant felbamate: Opposing effects on N-Methyl-D-aspartate and GABA-A receptors
153. Felbamate relieves several abnormal pain sensations in rats with an experimental peripheral neuropathy
154. Possible analgesic effect of vigabatrin in animal experimental chronic neuropathic pain
155. Tiagabine
156. An evaluation of the GABA uptake blocker tiagabine in animal models of neuropathic and nociceptive pain
157. Tiagabine nociception in rodents depends on GABA-B receptor activation: Parallel antinociception testing and medial hypothalamus GABA microdyalisis
158. Quantitative sensory testing
159. Painful and painless peripheral sensory neuropathies due to HIV infection: A comparison using quantitative sensory stimulation
160. Development and preliminary validation of a pain measure specific to neuropathic pain: The neuropathic pain scale